331 related articles for article (PubMed ID: 35326404)
21. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
[TBL] [Abstract][Full Text] [Related]
22. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2.
Franke K; Wang Z; Zuberbier T; Babina M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808264
[TBL] [Abstract][Full Text] [Related]
23. MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis?
Wang Z; Babina M
Exp Dermatol; 2020 Nov; 29(11):1104-1111. PubMed ID: 32866307
[TBL] [Abstract][Full Text] [Related]
24. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
[TBL] [Abstract][Full Text] [Related]
25. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
Roy S; Ganguly A; Haque M; Ali H
J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
[TBL] [Abstract][Full Text] [Related]
27. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
[TBL] [Abstract][Full Text] [Related]
28. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
29. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
30. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
[TBL] [Abstract][Full Text] [Related]
31. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
32. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
[TBL] [Abstract][Full Text] [Related]
33. Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo.
Kolkhir P; Pyatilova P; Ashry T; Jiao Q; Abad-Perez AT; Altrichter S; Vera Ayala CE; Church MK; He J; Lohse K; Metz M; Scheffel J; Türk M; Frischbutter S; Maurer M
J Allergy Clin Immunol; 2022 Jun; 149(6):1998-2009.e5. PubMed ID: 35283140
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
Front Immunol; 2020; 11():559589. PubMed ID: 33101278
[TBL] [Abstract][Full Text] [Related]
35. Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link.
Porebski G; Dziadowiec A; Rybka H; Kitel R; Kwitniewski M
Front Immunol; 2024; 15():1399459. PubMed ID: 38812508
[TBL] [Abstract][Full Text] [Related]
36. Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway.
Wang N; Wang J; Zhang Y; Zeng Y; Hu S; Bai H; Hou Y; Wang C; He H; He L
Biochem Pharmacol; 2021 Feb; 184():114401. PubMed ID: 33387483
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue.
Wang J; Zhang Y; Li C; Ding Y; Hu S; An H
Phytomedicine; 2020 Mar; 68():153149. PubMed ID: 32032836
[TBL] [Abstract][Full Text] [Related]
38. Degranulation of Mast Cells as a Target for Drug Development.
Yang BG; Kim AR; Lee D; An SB; Shim YA; Jang MH
Cells; 2023 May; 12(11):. PubMed ID: 37296626
[TBL] [Abstract][Full Text] [Related]
39. Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction.
Kumar M; Duraisamy K; Annapureddy RR; Chan CB; Chow BKC
J Allergy Clin Immunol; 2023 Apr; 151(4):1110-1122. PubMed ID: 36581009
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood cultured mast cells: Phenotypic and functional outcomes of different culture protocols.
Elst J; Sabato V; van der Poorten MM; Faber M; Van Gasse AL; De Puysseleyr LP; Bridts CH; Mertens C; Van Houdt M; Maurer M; Hagendorens MM; Ebo DG
J Immunol Methods; 2021 May; 492():113003. PubMed ID: 33647250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
